Isolation of Novel Animal Cell Lines Defective in Glycerolipid Biosynthesis Reveals Mutations in Glucose-6-phosphate Isomerase*

Glycerolipids are structural components for membranes and serve in energy storage. We describe here the use of a photodynamic selection technique to generate a population of Chinese hamster ovary cells that display a global deficiency in glycerolipid biosynthesis. One isolate from this population, GroD1, displayed a profound reduction in the synthesis of phosphatidylcholine, phosphatidylethanolamine, and triglycerides but presented high levels of phosphatidic acid and normal levels of phosphatidylinositol synthesis. This was accompanied by a reduction in phosphatidate phosphatase 1 (PAP1) activity. Expression cloning and sequencing of the cDNA obtained from GroD1 revealed a point mutation, Gly-189 → Glu, in glucose-6-phosphate isomerase (GPI), a glycolytic enzyme involved in an inherited disorder that results in anemia and neuromuscular symptoms in humans. GPI activity was reduced by 87% in GroD1. No significant differences were found in DNA synthesis, protein synthesis, and ATP levels, whereas glycerol 3-phosphate levels were increased in the mutant. Expression of wild-type hamster GPI restored GPI activity, glycerolipid biosynthesis, and PAP1 activity in GroD1. Two additional, independently isolated GPI-deficient mutants displayed similar phenotypes with respect to PAP1 activity and glycerolipid biosynthesis. These findings uncover a novel relationship between GPI, involved in carbohydrate metabolism, and PAP1, a lipogenic enzyme. These results may also help to explain neuromuscular symptoms associated with inherited GPI deficiency.

[1]  M. Montminy,et al.  TORC2 regulates hepatic insulin signaling via a mammalian phosphatidic acid phosphatase, LIPIN1. , 2009, Cell metabolism.

[2]  Takao Shimizu,et al.  Acyl-CoA:Lysophospholipid Acyltransferases* , 2009, Journal of Biological Chemistry.

[3]  A. Sanyal,et al.  Abnormalities of lipid metabolism in nonalcoholic fatty liver disease. , 2008, Seminars in liver disease.

[4]  G. Carman,et al.  Phosphatidic acid mediates demyelination in Lpin1 mutant mice. , 2008, Genes & development.

[5]  S. Grundy Metabolic Syndrome Pandemic , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[6]  P. Bhatnagar,et al.  From a glucocentric to a lipocentric approach towards metabolic syndrome. , 2008, Drug discovery today.

[7]  G. Thomas,et al.  Nutrient sensing in the mTOR/S6K1 signalling pathway. , 2007, Biochemical Society transactions.

[8]  K. Reue,et al.  Three Mammalian Lipins Act as Phosphatidate Phosphatases with Distinct Tissue Expression Patterns* , 2006, Journal of Biological Chemistry.

[9]  G. Carman,et al.  Roles of phosphatidate phosphatase enzymes in lipid metabolism. , 2006, Trends in biochemical sciences.

[10]  G. Carman,et al.  The Saccharomyces cerevisiae Lipin Homolog Is a Mg2+-dependent Phosphatidate Phosphatase Enzyme*♦ , 2006, Journal of Biological Chemistry.

[11]  R. DePinho,et al.  The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin , 2005, Science.

[12]  M. Montminy,et al.  The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism , 2005, Nature.

[13]  J. Rumberger,et al.  Role of Hexosamine Biosynthesis in Glucose-mediated Up-regulation of Lipogenic Enzyme mRNA Levels , 2003, Journal of Biological Chemistry.

[14]  S. Copley Enzymes with extra talents: moonlighting functions and catalytic promiscuity. , 2003, Current opinion in chemical biology.

[15]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[16]  J. Lawrence,et al.  Insulin-stimulated phosphorylation of lipin mediated by the mammalian target of rapamycin , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. Hardie,et al.  AMP‐activated protein kinase: the energy charge hypothesis revisited , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[18]  J. Chirgwin,et al.  The crystal structure of human phosphoglucose isomerase at 1.6 A resolution: implications for catalytic mechanism, cytokine activity and haemolytic anaemia. , 2001, Journal of molecular biology.

[19]  C. Hsiao,et al.  The Crystal Structure of Phosphoglucose Isomerase/Autocrine Motility Factor/Neuroleukin Complexed with Its Carbohydrate Phosphate Inhibitors Suggests Its Substrate/Receptor Recognition* , 2000, The Journal of Biological Chemistry.

[20]  M. Lakomek,et al.  Glucose-6-phosphate isomerase deficiency. , 2000, Bailliere's best practice & research. Clinical haematology.

[21]  J. Yokota,et al.  The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein 1 , 1999, FEBS letters.

[22]  K. Hanada,et al.  Mammalian Cell Mutants Resistant to a Sphingomyelin-directed Cytolysin , 1998, The Journal of Biological Chemistry.

[23]  H. Muirhead,et al.  Molecular basis of neurological dysfunction coupled with haemolytic anaemia in human glucose-6-phosphate isomerase (GPI) deficiency , 1998, Human Genetics.

[24]  D. Brindley,et al.  Mammalian Lipid Phosphate Phosphohydrolases* , 1998, The Journal of Biological Chemistry.

[25]  L. Forman,et al.  Glucosephosphate isomerase (GPI) deficiency mutations associated with hereditary nonspherocytic hemolytic anemia (HNSHA). , 1997, Blood cells, molecules & diseases.

[26]  R. Zoeller,et al.  An Animal Cell Mutant with a Deficiency in Acyl/Alkyl-dihydroxyacetone-phosphate Reductase Activity , 1997, The Journal of Biological Chemistry.

[27]  J. Balsinde,et al.  Bromoenol Lactone Inhibits Magnesium-dependent Phosphatidate Phosphohydrolase and Blocks Triacylglycerol Biosynthesis in Mouse P388D1 Macrophages* , 1996, The Journal of Biological Chemistry.

[28]  T Shinozaki,et al.  Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. , 1996, Cancer research.

[29]  W. Xu,et al.  The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase. , 1996, Blood.

[30]  K. Larsson,et al.  A gene encoding sn‐glycerol 3‐phosphate dehydrogenase (NAD+) complements an osmosensitive mutant of Saccharomyces cerevisiae , 1993, Molecular microbiology.

[31]  M. Nishijima,et al.  A somatic cell mutant defective in phosphatidylglycerophosphate synthase, with impaired phosphatidylglycerol and cardiolipin biosynthesis. , 1993, The Journal of biological chemistry.

[32]  R. Shalev,et al.  GPI Mount Scopus — a variant of glucosephosphate isomerase deficiency , 1993, Annals of Hematology.

[33]  J. Gordon,et al.  Characterization of the peripheral neuropathy in neonatal and adult mice that are homozygous for the fatty liver dystrophy (fld) mutation. , 1991, The Journal of biological chemistry.

[34]  H. Land,et al.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.

[35]  P. Hasleton,et al.  The value of tumour markers in lung cancer. , 1988, British Journal of Cancer.

[36]  C. Raetz,et al.  A possible role for plasmalogens in protecting animal cells against photosensitized killing. , 1988, The Journal of biological chemistry.

[37]  J. Richardson,et al.  Amino acid preferences for specific locations at the ends of alpha helices. , 1988, Science.

[38]  Arsène Burny,et al.  The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase , 1988, Nature.

[39]  W. R. Bishop,et al.  Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. , 1986, The Journal of biological chemistry.

[40]  C. Raetz,et al.  Isolation of animal cell mutants deficient in plasmalogen biosynthesis and peroxisome assembly. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Frazier,et al.  Isolation and characterization of a Chinese hamster ovary cell line requiring ethanolamine or phosphatidylserine for growth and exhibiting defective phosphatidylserine synthase activity. , 1986, The Journal of biological chemistry.

[42]  M. Nishijima,et al.  Isolation of a somatic-cell mutant defective in phosphatidylserine biosynthesis. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[43]  C. Raetz,et al.  Autoradiographic detection of animal cell membrane mutants altered in phosphatidylcholine synthesis. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[44]  W. Valentine,et al.  Hereditary glucosephosphate isomerase deficiency. A review. , 1974, American journal of clinical pathology.

[45]  N. Radin,et al.  The enzymatic formation of sphingomyelin from ceramide and lecithin in mouse liver. , 1974, The Journal of biological chemistry.

[46]  P. Maitra Glucose and Fructose Metabolism in a Phosphoglucoisomeraseless Mutant of Saccharomyces cerevisiae , 1971, Journal of bacteriology.

[47]  E. P. Kennedy,et al.  The biosynthesis of phosphatidylglycerol. , 1963, The Journal of biological chemistry.

[48]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[49]  B. Agranoff,et al.  The enzymatic synthesis of inositol phosphatide. , 1958, The Journal of biological chemistry.

[50]  E. P. Kennedy,et al.  The enzymatic dephosphorylation of phosphatidic acids. , 1957, The Journal of biological chemistry.

[51]  E. P. Kennedy,et al.  The function of cytidine coenzymes in the biosynthesis of phospholipides. , 1956, The Journal of biological chemistry.

[52]  E. P. Kennedy,et al.  The enzymatic synthesis of triglycerides. , 1956, The Journal of biological chemistry.

[53]  M. Nanjundan,et al.  Pulmonary phosphatidic acid phosphatase and lipid phosphate phosphohydrolase. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[54]  S. Merkle,et al.  Glucose-6-phosphate isomerase deficiency associated with nonspherocytic hemolytic anemia in the mouse: an animal model for the human disease , 1993 .

[55]  G. Carman,et al.  Phosphatidate phosphatase from yeast. , 1991, Methods in enzymology.

[56]  K. Brand,et al.  The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer. , 1990, Cancer investigation.

[57]  T. Rogers,et al.  Identification and characterization of lymphocyte hybridomas by electrophoresis of glucose-6-phosphate isomerase isozymes. , 1983, Methods in Enzymology.

[58]  R. W. Gracy,et al.  Phosphoglucose isomerase of human erythrocytes and cardiac tissue. , 1975, Methods in enzymology.